SCHEMBL3743771

SCHEMBL3743771

Cc1cccc(C(C#N)N2CCN3CCCC3C2)n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
ALDH1A1 P00352 3/20 0.43
POLB P06746 2/20 0.43
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41
TSHR P16473 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CHRM2 P08172 4/20 0.38
CHRM1 P11229 4/20 0.38
CHRM4 P08173 3/20 0.38
CHRM3 P20309 2/20 0.38
CHRM5 P08912 1/20 0.38
NPSR1 Q6W5P4 2/20 0.36
CYP2C9 P11712 1/20 0.36
SOS1 Q07889 4/20 0.36
USP2 O75604 1/20 0.35
HRH3 Q9Y5N1 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3637374 1.00 KMT2A (0.43) KMT2AMEN1ALDH1A1POLBCYP3A4
SCHEMBL13984537 0.82 KMT2A (0.43) KMT2AMEN1ALDH1A1POLBCYP3A4
SCHEMBL3739429 0.79 MEN1 (0.43) KMT2AMEN1ALDH1A1POLBCYP3A4
SCHEMBL3634477 0.79 MEN1 (0.43) KMT2AMEN1ALDH1A1POLBCYP3A4
SCHEMBL3637907 0.78 KMT2A (0.44) KMT2AMEN1ALDH1A1POLBCYP3A4
SCHEMBL3746272 0.78 MEN1 (0.46) KMT2AMEN1ALDH1A1POLBCYP3A4
SCHEMBL3637387 0.78 MEN1 (0.46) KMT2AMEN1ALDH1A1POLBCYP3A4
SCHEMBL3637861 0.77 KMT2A (0.43) KMT2AMEN1ALDH1A1POLBCYP3A4
SCHEMBL13044870 0.76 CHRM2 (0.39) KMT2AMEN1ALDH1A1POLBCYP3A4
SCHEMBL13044806 0.76 KMT2A (0.42) KMT2AMEN1ALDH1A1POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R KMT2A 3646/4885MEN1 3070/4885ALDH1A1 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.